and Blood Institute Committee to Evaluate the Artificial Heart Program of the National Heart, Lung – författare
Visar alla böcker från författaren . Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
E-bok
PDF, Engelska, 1991399 kr
Läs direkt efter köp
A significant medical event is expected in 1992: the first human use of a fully implantable, long-term cardiac assist device. This timely volume reviews the artificial heart program—and in particular, the National Institutes of Health''s major investment—raising important questions.
The volume includes:
Consideration of the artificial heart versus heart transplantation and other approaches to treating end-stage heart disease, keeping in mind the different outcomes and costs of these treatments. A look at human issues, including the number of people who may require the artificial heart, patient quality of life, and other ethical and societal questions. Examination of how this technology''s use can be targeted most appropriately. Attention to achieving access to this technology for all those who can benefit from it.The committee also offers three mechanisms to aid in allocating research and development funds.
Inbunden, Engelska, 1991
1 400 kr
Tillfälligt slut
A significant medical event is expected in 1992: the first human use of a fully implantable, long-term cardiac assist device. This timely volume reviews the artificial heart program--and in particular, the National Institutes of Health's major investment--raising important questions. The volume includes: * Consideration of the artificial heart versus heart transplantation and other approaches to treating end-stage heart disease, keeping in mind the different outcomes and costs of these treatments. * A look at human issues, including the number of people who may require the artificial heart, patient quality of life, and other ethical and societal questions. * Examination of how this technology's use can be targeted most appropriately. * Attention to achieving access to this technology for all those who can benefit from it. The committee also offers three mechanisms to aid in allocating research and development funds.